RPG Life Sciences Limited — Board Meeting, 17-10-2025: Outcome of Board Meeting
17-10-2025 | 05:53 pm
17-10-2025 | 05:53 pm
RPG Life Sciences' Board approved Q2/H1 FY25 results: Revenue ₹181.68 Cr (Q2) & ₹350.60 Cr (H1), PAT ₹36.85 Cr (Q2, includes ₹11.22 Cr exceptional gain). CFO Vishal Shah resigned, effective Oct 23.
No comments yet. Be the first to comment!
